Telaprevir or boceprevir in HIV/HCV-1 co-infected patients in a real-life setting. Interim analysis (24 weeks). COINFECOVA-SEICV study

INTRODUCTION: In general, HIV co-infected patients included in clinical trials evaluating the hepatitis C virus (HCV) therapy with telaprevir (TVR) or boceprevir (BOC) with advanced fibrosis, are scarce. We analyze data concerning the use of these drugs in a real-life clinical setting with patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Minguez, Carlos, Ortega, Enrique, Flores, Juan, Carmena, Jorge, Masiá, Mar, Montero, Marta, Reus, Sergio, Tornero, Carlos, Jose Galindo, Maria, Garcia-Deltoro, Miguel, Amador, Concepción, María Cuadrado, Jose, Usó, Jorge, López-Aldeguer, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P102
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224840/
https://www.ncbi.nlm.nih.gov/pubmed/25394138
http://dx.doi.org/10.7448/IAS.17.4.19634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224840/
https://www.ncbi.nlm.nih.gov/pubmed/25394138
http://dx.doi.org/10.7448/IAS.17.4.19634

Ejemplares similares